Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indirect CFTR mutation identification by PCR/OLA anomalous electropherograms.

Pietro Stanziale1, Maria Savino, Patrizia De Bonis

  • 1Medical Genetics Service, IRCCS Hospital Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

Genetic Testing
|December 29, 2005
PubMed
Summary

The PCR/OLA assay efficiently screens for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations. Anomalous results revealed two novel point mutations, a large deletion, and a polymorphism, expanding the assay's utility for CFTR-related disorder diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanding the clinical spectrum of RNU4ATAC-opathies: more frequent and diverse than assumed.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Clinical and Genetic Heterogeneity of Factor XI Deficiency: Insights from a Southern Italian Cohort.

International journal of molecular sciences·2025
Same author

Integrated Genomic Approach: A Five Exon Intragenic Deletion in UNC80 Combines With a Novel Splice Variant to Cause IHPRF2 Syndrome in an Italian Family.

American journal of medical genetics. Part A·2025
Same author

Clinical and Endoscopic-Histological Features of Multifocal and Corpus-Restricted Atrophic Gastritis Patients With Non-Cardia Gastric Cancer or Dysplasia: A Multicenter, Cross-Sectional Study.

Clinical and translational gastroenterology·2025
Same author

Effectiveness and tolerability of givosiran for the management of acute hepatic porphyria: A monocenter real-life evaluation.

Molecular genetics and metabolism reports·2024
Same author

Combined exome and whole transcriptome sequencing identifies a de novo intronic SRCAP variant causing DEHMBA syndrome with severe sleep disorder.

Journal of human genetics·2024

Area of Science:

  • Human Genetics
  • Molecular Biology
  • Medical Diagnostics

Background:

  • Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibrosis (CF) and other CFTR-related disorders.
  • Established PCR/OLA assays detect 31 known CFTR mutations, including the 24 most common globally.

Purpose of the Study:

  • To evaluate the CFTR genotype in 1812 individuals from central-southern Italy using the PCR/OLA assay.
  • To identify novel CFTR mutations and polymorphisms beyond the standard assay panel.

Main Methods:

  • Screening of 1812 individuals using the PCR/OLA assay for CFTR gene mutations.
  • Analysis of anomalous electropherograms to identify unknown mutations and polymorphisms.
  • Haplotype and real-time PCR analysis for a large gene deletion.

Related Experiment Videos

Main Results:

  • Five cases with anomalous electropherograms led to the identification of two novel point mutations (D110H, S589N) and a large deletion (CFTRdel14b_17b) in the homozygous state.
  • An exonic polymorphism (c.4002A > G) was also identified.
  • The PCR/OLA assay demonstrated utility beyond detecting known mutations.

Conclusions:

  • The PCR/OLA assay is an efficient and user-friendly method for screening known CFTR mutations.
  • The assay can also function as a mutation/polymorphism-scanning tool for specific gene regions.
  • This expands diagnostic capabilities for CFTR-related disorders.